Harrow, Inc.
HROW
#5830
Rank
S$1.55 B
Marketcap
S$41.45
Share price
-0.09%
Change (1 day)
-19.86%
Change (1 year)

Earnings for Harrow, Inc. (HROW)

Earnings in 2026 (TTM): -S$13.49 Million

According to Harrow, Inc.'s latest financial reports the company's current earnings are S$0.27 Billion. In 2025 the company made an earning of S$29.42 Million, an increase over its 2024 earnings that were of S$7.05 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Harrow, Inc. from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$13.49 Million-145.84%
2025 S$29.42 M317.34%
2024 S$7.05 M-329.09%
2023 -S$3.08 Million-224.34%
2022 S$2.47 M3.01%
2021 S$2.4 M149.06%
2020 S$0.96 M434.29%
2019 S$0.18 M-102.68%
2018 -S$6.73 Million-57.11%
2017 -S$15.69 Million-21.93%
2016 -S$20.1 Million5.11%
2015 -S$19.12 Million46.16%
2014 -S$13.09 Million32.68%
2013 -S$9.86 Million42.63%
2012 -S$6.92 Million
2010 -S$3.2 Million-45.76%
2009 -S$5.89 Million21.83%
2008 -S$4.84 Million-491.97%
2007 S$1.23 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-S$0.21 Billion 1,423.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-S$23.42 Million 73.81%๐Ÿ‡บ๐Ÿ‡ธ USA